PolyNovo [ASX:PNV] shares are rising today after the biotech stock reported its indicative half-year trading results.
The Imugene [ASX:IMU] share price is up 6% following a supply agreement update. Imugene, the biotech stock, gained 600% over the last 12 months.
Up-and-coming biotech player Mesoblast [ASX:MSB] is on the up today. The regenerative medicine company announced some promising results from a Phase III drug trial from data that was shared at the American Heart Association’s annual ‘Scientific Sessions’, an exhibition of the latest findings and insights into all things heart health related.
It was an opinion piece discussing the recent listing (at the time) of Compass Pathways PLC [NASDAQ:CMPS]. A biotech stock with a very distinct twist...
Tiny medtech stock Oneview Healthcare PLC [ASX:ONE] is on the up today. The ONE share price currently trading 6.98% higher at time of writing, paring back earlier gains of as much as 20.9% today.
MGC Pharmaceuticals Ltd [ASX:MXC] share price is currently up 6.90%. The MGC Pharmaceuticals Ltd [ASX:MXC] announced that its distribution partner placed an order for 1,000 units of MXC’s CimetrA on an expedited basis.
MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import. The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.
The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing.
The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.
Small-cap biotech stock Immutep Ltd [ASX:IMM] is on the up today. The IMM share price is currently trading 7.92% higher at time of writing...